White label – Pompe disease - ClinicalTrials.eu

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Not recruiting

3 1 1 1
Investigated Drugs:
+2
Study on RPT193 for Adults with Moderate-to-Severe Asthma Partially Controlled by Inhaled Corticosteroids and Long-Acting Beta 2 Agonists

Not recruiting

2 1 1
Investigated Diseases:
- Asthma
Investigated Drugs:
Study on the Effectiveness and Safety of MC2-25 Cream for Women with Vulvar Lichen Sclerosus

Not recruiting

2 1
Investigated Diseases:
- Lichen sclerosus
Investigated Drugs:
- Alanyl Glutamine
Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients

Not recruiting

3 1 1
Investigated Diseases:
- COVID-19
Investigated Drugs:
- Abatacept
+3
Study on Linaclotide for Treating Functional Constipation in Children Aged 6 Months to Less Than 2 Years

Not recruiting

2 1 1
Investigated Diseases:
- Constipation
Investigated Drugs:
- Linaclotide
Study on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy

Not recruiting

3 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
+3
Study of Pembrolizumab and Lenvatinib for Patients with Advanced or Recurrent Endometrial Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Endometrial cancer
Investigated Drugs:
+1
Study on the Safety and Pain Relief of Nasal Spray with Ketamine Hydrochloride and Sufentanil Citrate for Children with Moderate to Severe Pain

Not recruiting

2 1 1
Investigated Diseases:
- Pain
Investigated Drugs:
- Sufentanil Citrate
- Ketamine Hydrochloride
Study of Patritumab Deruxtecan for Patients with Brain Metastases from Advanced Breast or Lung Cancer and Leptomeningeal Disease from Solid Tumors

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Patritumab Deruxtecan
Study on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease

Not recruiting

3 1 1
Investigated Diseases:
- Graves’ disease

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies